At the completion of this article, the reader should be able to improve their myopia management approach, including... Recognise the...
Read moreDetailsAustralian eyecare professionals are confident in the nation’s ability to combat the global myopia epidemic. Equipped with industry-leading products, a...
Read moreDetailsTokyo Medical and Dental University (TMDU) will introduce the Eyerising Myopia Management Device for its myopia patients as part of...
Read moreDetailsZEISS has formed a new Myopia Advisory Board, a think-tank of leading experts – including three Australians – whose scientific...
Read moreDetailsStellest lenses demonstrated significant myopia control in their original two-year clinical trial. After extending the study for another two years,...
Read moreDetailsAt the completion of this article, the reader should be able to improve their management of progressive myopia with atropine,...
Read moreDetailsAustralian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...
Read moreDetailsAs students return to classrooms across Australia, lens manufacturer HOYA is urging optometrists, parents and educators to prioritise discussions...
Read moreDetailsMyopia dominated the clinical program at O=MEGA23 and the 4th World Congress of Optometry, but there were also many other...
Read moreDetailsAustralian hyperparallel OCT (HP-OCT) manufacturer Cylite has entered an agreement to integrate the recently launched PreMO myopia app into its...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited